Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSCW) Prepaid Assets (2020 - 2025)

Historic Prepaid Assets for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to $1.3 million.

  • Ensysce Biosciences' Prepaid Assets fell 6034.88% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 6034.88%. This contributed to the annual value of $1.7 million for FY2024, which is 6095.21% up from last year.
  • Ensysce Biosciences' Prepaid Assets amounted to $1.3 million in Q3 2025, which was down 6034.88% from $1.9 million recorded in Q2 2025.
  • Ensysce Biosciences' 5-year Prepaid Assets high stood at $3.2 million for Q2 2022, and its period low was $261517.0 during Q2 2021.
  • Its 5-year average for Prepaid Assets is $1.9 million, with a median of $1.8 million in 2022.
  • Its Prepaid Assets has fluctuated over the past 5 years, first surged by 395013.14% in 2021, then tumbled by 6034.88% in 2025.
  • Quarter analysis of 5 years shows Ensysce Biosciences' Prepaid Assets stood at $2.9 million in 2021, then plummeted by 36.98% to $1.8 million in 2022, then tumbled by 42.21% to $1.1 million in 2023, then soared by 60.95% to $1.7 million in 2024, then decreased by 27.22% to $1.3 million in 2025.
  • Its Prepaid Assets was $1.3 million in Q3 2025, compared to $1.9 million in Q2 2025 and $1.3 million in Q1 2025.